Back
Collegium Pharmaceutical Vs. Rigel Pharmaceuticals Industry Stock Comparison
Buy
70
COLL
Collegium Pharmaceutical
Last Price:
38.93
Seasonality Move:
31.73%
Buy
61
RIGL
Rigel Pharmaceuticals
Last Price:
13.66
Seasonality Move:
-5.2%
Buy
70
Collegium Pharmaceutical (COLL)
is a Buy
Is Collegium Pharmaceutical a Buy, Sell or Hold?
- The current Collegium Pharmaceutical [COLL] share price is $38.94. The Score for COLL is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- COLL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Rigel Pharmaceuticals (RIGL)
is a Buy
Is Rigel Pharmaceuticals a Buy, Sell or Hold?
- The current Rigel Pharmaceuticals [RIGL] share price is $13.64. The Score for RIGL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- RIGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $38.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing slight buying pressure.
RIGL Stock Price Chart
What is Rigel Pharmaceuticals's stock price today?
-
The Rigel Pharmaceuticals share price today is $13.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RIGL is experiencing selling pressure, which indicates risk of future bearish movement.
COLL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.6 | Buy |
Relative Strength Index (14 RSI): | 62.39 | Buy |
Chaikin Money Flow: | 58630 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.01 - 38.09) | Buy |
Bollinger Bands (100): | (32.21 - 37.01) | Buy |
RIGL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.54 | Buy |
Relative Strength Index (14 RSI): | 61.4 | Buy |
Chaikin Money Flow: | -20834 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.59 - 13.57) | Buy |
Bollinger Bands (100): | (8.97 - 12.33) | Buy |
COLL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.31 | Buy |
20-day SMA: | 37.37 | Buy |
50-day SMA: | 35.81 | Buy |
200-day SMA: | 34.41 | Buy |
8-day EMA: | 37.78 | Buy |
20-day EMA: | 37.21 | Buy |
50-day EMA: | 36.12 | Buy |
200-day EMA: | 33.36 | Buy |
RIGL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.4 | Buy |
20-day SMA: | 13.24 | Buy |
50-day SMA: | 11.74 | Buy |
200-day SMA: | 11.85 | Buy |
8-day EMA: | 13.5 | Buy |
20-day EMA: | 13.09 | Buy |
50-day EMA: | 12.07 | Buy |
200-day EMA: | 11.57 | Buy |
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.10 per share, an increase this year of $0.99 per share, and an increase next year of $0.44 per share.
Rigel Pharmaceuticals Earnings Growth & RIGL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.72 per share, an increase next quarter of $0.13 per share, an increase this year of $1.40 per share, and an increase next year of $1.10 per share.
Collegium Pharmaceutical Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rigel Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |